The Incoming person shall handle QMS with a special focus to Change Controls, Complaints, APQRS and Self Inspection
Preparation, Review and approval of Annual Product Review.
Logging of complaints & Intake, follow up and investigation of market complaints.
Change control management of entire site. Responsible for review and evaluation of change control.
Conduct reviewer qualification based on the request and to maintain qualified reviewer list.
Conducting the self-inspection, walk-through audit as per schedule/plan, reporting and follow up for relevant actions.
Preparation, review and approval of standard Operating Procedures.
Gap assessment of procedures.
Preparation, review and approval of Risk Assessment.
Responsible for Initiation, review, implementation and closure of Deviations and CAPA.
Support of internal / regulatory audits conducted at site.
Preparations, review and approval of protocols and reports.
Support for the preparation of Quality monthly reports.
Responsible to keep the workplace neat and clean. Maintain 5S and support for its improvement.
Responsible to perform any other work assigned by HOD.

Endo combined with Mallinckrodt Pharmaceuticals in 2025 to better serve customers and improve outcomes for the patients we support.
From this union, we established two focused, standalone companies:
– Keenova Therapeutics, a branded therapeutics business
– Par Health, a generics and sterile injectables business
To learn more, follow Keenova and Par Health on LinkedIn and visit keenova.com and parhealth.com.